Le Lézard
Classified in: Health, Business
Subjects: TNM, PER, PET

Animal Dermatology Group Expands into Austin, Texas

IRVINE, Calif., Sept. 9, 2021 /PRNewswire/ -- Animal Dermatology Group, Inc. (ADG) has acquired Animal Allergy and Dermatology Center, a premier veterinary specialty practice located in Austin, Texas.

Animal Dermatology Group Acquires Animal Allergy & Dermatology Center, Expands Dermatology Expertise into Austin, Texas

Established in 1999, Animal Allergy and Dermatology Center specializes in diagnosing and treating the underlying cause of skin conditions and ear issues of their pet patients throughout central Texas and beyond. Under the leadership of Patrick Nichols, DVM, the center utilizes advanced diagnostic procedures to develop custom treatment plans for their patients. "Addressing the problem at its source, instead of stopgap measures which only temporarily treat the recurring symptoms, saves our clients time, money, and most importantly, their pets a lifetime of suffering," said Dr. Nichols.

ADG, operating veterinary specialty practices under the name "Animal Dermatology Clinic" in the US, Australia and New Zealand, is recognized as a global leader in innovative veterinary dermatology, providing unsurpassed care to patients and valuable peace of mind to pet owners. Animal Allergy and Dermatology Center will become Animal Dermatology Clinic ? Austin. "We are excited to have Dr. Nichols and his team join ADG. Their innovative clinical approach and patient-centric outlook is a great fit at ADG", said Steven Mrha, CEO of Animal Dermatology Group.

About Animal Dermatology Group, Inc.

Animal Dermatology Group, Inc. is a privately-owned, international veterinary dermatology specialty company that seeks to establish industry-leading position in the large and rapidly growing specialty care segment of the animal health market. Founded by Dr. Craig Griffin in 1980 with a mission to make state-of-the-art veterinary dermatology care available to pet owners everywhere, today ADG's pet health reach includes over forty full-time and satellite locations throughout the United States, Australia and New Zealand, with an elite team of veterinarians engaged in clinical care, research and academic training to advance the field of veterinary dermatology. ADG is the first non-university based organization approved by the American College of Veterinary Dermatology (ACVD) to provide a residency program, and today the program continues to train ACVD residents to excel in the field. ADG is very proud of this important responsibility to help shape the next generation of veterinary dermatology practitioners. ADG strives to develop and refine cutting edge testing and treatment techniques and bring unique, specialized dermatology care to pets.

For more information, visit www.animaldermatology.com.

SOURCE Animal Dermatology Clinic Management Group, Inc.

These press releases may also interest you

at 20:57
The Salt River Pima-Maricopa Indian Community ("SRPMIC") has awarded a grant of $50,000 to the Veterans Medical Leadership Council (VMLC), through their 12% Gaming Grant Program. The VMLC supports Veterans of any era who have a verified and bonified...

at 20:36
Thermo Fisher Scientific Inc. ("Thermo Fisher") announced today that it has priced an offering of $5.85 billion aggregate principal amount (the "Offering") of the following notes, each issued at par: $1,000,000,000 aggregate principal amount of its...

at 20:26
Molecular Lab Partners LLC, a national provider of turn-key Physician Office Laboratory (POL) Solutions, announced strong growth during the third quarter of 2021. The company achieved 86% revenue growth during the quarter.  The growth is reflective...

at 20:00
The sexual wellness market is expected to grow by USD 32.02 billion from 2021-2025, progressing at a CAGR of 10.86% according to the latest market report by Technavio....

at 19:45
Heart to Heart Hospice, a leader in hospice services since 2003, will soon be opening a new Hospice Inpatient Center in Houston. The facility is located inside Proveer at Northgate (formerly Pathways Memory Care) at 2930 Cypress Grove Meadows Drive....

at 19:35
Merck , known as MSD outside the United States and Canada, is voluntarily recalling one lot of CUBICIN® (daptomycin for injection) 500 mg for intravenous use, Lot 934778, Exp June 2022. Because treatment with CUBICIN is likely to be initiated at a...

News published on 9 september 2021 at 11:11 and distributed by: